Research map: Targeting ACSF2 overcomes Ara-C resistance in acute myeloid leukemia via the cholesterol metabolism-ERK signaling axis
Back to the article
Papers in this map
- Mitochondria: In Sickness and in Health · Jodi M. Nunnari · 2012 · 3562 citations · Cited by this paper
- Cholesterol in hematological malignancies: metabolism, mechanisms, and clinical implications · Yaqin Zhang · 2026 · Cites this paper
- Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms · 2026 · Related
- Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN · Hartmut Döhner · 2022 · 3298 citations · Cited by this paper
- Rbm5 sustains leukemia stem cells through a Myc-driven transcriptional circuitry · 2026 · Related
- JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles · Jaime Abraham Castro-Mondragon · 2021 · 2211 citations · Cited by this paper
- Cohesin haploinsufficiency and inv(16) cooperate to reinforce Fli1 gene transcriptional programs during acute myeloid leukemia initiation and maintenance · 2026 · Related
- ERK signalling: a master regulator of cell behaviour, life and fate · Hugo Lavoie · 2020 · 1262 citations · Cited by this paper
- Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis · 2026 · Related
- SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology · Hitoshi Shimano · 2017 · 1214 citations · Cited by this paper
- FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia · 2026 · Related
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells · Courtney L. Jones · 2018 · 591 citations · Cited by this paper
- IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms · 2026 · Related
- Acute myeloid leukaemia · Courtney Denton Dinardo · 2023 · 438 citations · Cited by this paper
- Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma · 2026 · Related
- Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome · Paul A. Watkins · 2007 · 387 citations · Cited by this paper
- Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry · 2026 · Related
- AnimalTFDB 4.0: a comprehensive animal transcription factor database updated with variation and expression annotations · Wen‐Kang Shen · 2022 · 383 citations · Cited by this paper
- Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms · 2026 · Related
- An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance · Assaf C. Bester · 2018 · 337 citations · Cited by this paper
- Stuck in traffic: CART cells targeting the tumor microenvironment in hematological malignancies, current advances and future perspectives · 2026 · Related
- GTRD: an integrated view of transcription regulation · Semyon K. Kolmykov · 2020 · 314 citations · Cited by this paper
- Recent advances in targeted therapies in acute myeloid leukemia · Rahul S. Bhansali · 2023 · 288 citations · Cited by this paper
- Leukemic stem cells and therapy resistance in acute myeloid leukemia · Patrick Stelmach · 2023 · 240 citations · Cited by this paper
- Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management · Shai O. Shimony · 2025 · 211 citations · Cited by this paper
- High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study · François Vergez · 2011 · 204 citations · Cited by this paper
- Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance · Nick van Gastel · 2020 · 138 citations · Cited by this paper
- Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia · Maria Rosaria Ricciardi · 2005 · 128 citations · Cited by this paper
- Contemporary Management of Acute Myeloid Leukemia · Sangeetha Venugopal · 2024 · 89 citations · Cited by this paper
- Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts · Paolo Lunghi · 2003 · 85 citations · Cited by this paper
- Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia · Ying Song · 2022 · 64 citations · Cited by this paper
- The roles and mechanisms of SREBP1 in cancer development and drug response · Ying He · 2023 · 55 citations · Cited by this paper
- An Overview of Targeted Therapies in Acute Myeloid Leukemia · Sven Turkalj · 2023 · 48 citations · Cited by this paper
- BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4 · Ken Morita · 2015 · 44 citations · Cited by this paper
- TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1 · Yihua Pang · 2020 · 42 citations · Cited by this paper
- SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance · Guojiang Wei · 2025 · 30 citations · Cited by this paper
- CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation · Jin Feng Qiu · 2024 · 29 citations · Cited by this paper
- Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities · Vilma Dembitz · 2025 · 28 citations · Cited by this paper
- Inhibition of ACSF2 protects against renal ischemia/reperfusion injury via mediating mitophagy in proximal tubular cells · Haoyu Shi · 2023 · 27 citations · Cited by this paper
Source: OpenAlex (CC0)